The ups and downs of paclitaxel-coated balloons and paclitaxel eluting stents: do the conclusions of SWEDEPAD 2 change our practice? Should we be concerned about mortality (again)?

More search options...

Müller-Hülsbeck, S; Fanelli, F; Haage, P; Hamady, M; Kobeiter, H; Loffroy, R; O’Sullivan, G; Ratnam, LA; van Rijswijk, CSP; Ruffino, MA; et al. Müller-Hülsbeck, S; Fanelli, F; Haage, P; Hamady, M; Kobeiter, H; Loffroy, R; O’Sullivan, G; Ratnam, LA; van Rijswijk, CSP; Ruffino, MA; Wolf, F; Morgan, RA (2026) The ups and downs of paclitaxel-coated balloons and paclitaxel eluting stents: do the conclusions of SWEDEPAD 2 change our practice? Should we be concerned about mortality (again)? CVIR Endovascular, 9 (1). p. 11. ISSN 2520-8934 https://doi.org/10.1186/s42155-025-00645-9
SGUL Authors: Morgan, Robert Anthony

PDF Published Version
Available under License Creative Commons Attribution.
Download (842kB)

Official URL: https://doi.org/10.1186/s42155-025-00645-9

Abstract

The use of paclitaxel-coated devices (PCDs) in peripheral arterial disease continues to generate interest and controversy. The PCD journey to date has been a story of highs and lows. The recently published SWEDEPAD 1 and 2 trials have rekindled discussion regarding efficacy and a potential link to mortality.

Item Type:

Article

Additional Information:

© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

SGUL Research Institute / Research Centre:

Academic Structure > Cardiovascular & Genomics Research Institute
Academic Structure > Cardiovascular & Genomics Research Institute > Clinical Cardiology

Journal or Publication Title:

CVIR Endovascular

ISSN:

2520-8934

Language:

Media of Output:

Electronic

Related URLs: